Package 64764-107-11

Brand: entyvio

Generic: vedolizumab
NDC Package

Package Facts

Identity

Package NDC 64764-107-11
Digits Only 6476410711
Product NDC 64764-107
Product ID 64764-107_24e7cbcf-82ec-4276-ba13-e719bedf3ed2
Description

1 TRAY in 1 CARTON (64764-107-11) / 1 SYRINGE in 1 TRAY (64764-107-10) / .68 mL in 1 SYRINGE

Marketing

Marketing Status
Marketed Since 2023-09-27
Brand entyvio
Generic vedolizumab
Sample Package No

Linked Drug Pages (1)

ENTYVIO, ENTYVIO Pen, Entyvio ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "24e7cbcf-82ec-4276-ba13-e719bedf3ed2", "openfda": {"nui": ["N0000175775", "N0000175774"], "unii": ["9RV78Q2002"], "rxcui": ["1538137", "1538142", "2667332", "2667336", "2667339", "2667342"], "spl_set_id": ["6e94621c-1a95-4af9-98d1-52b9e6f1949c"], "pharm_class_epc": ["Integrin Receptor Antagonist [EPC]"], "pharm_class_moa": ["Integrin Receptor Antagonists [MoA]"], "manufacturer_name": ["Takeda Pharmaceuticals America, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TRAY in 1 CARTON (64764-107-11)  / 1 SYRINGE in 1 TRAY (64764-107-10)  / .68 mL in 1 SYRINGE", "package_ndc": "64764-107-11", "marketing_start_date": "20230927"}], "brand_name": "ENTYVIO", "product_id": "64764-107_24e7cbcf-82ec-4276-ba13-e719bedf3ed2", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Integrin Receptor Antagonist [EPC]", "Integrin Receptor Antagonists [MoA]"], "product_ndc": "64764-107", "generic_name": "vedolizumab", "labeler_name": "Takeda Pharmaceuticals America, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ENTYVIO", "active_ingredients": [{"name": "VEDOLIZUMAB", "strength": "108 mg/.68mL"}], "application_number": "BLA761133", "marketing_category": "BLA", "marketing_start_date": "20230927", "listing_expiration_date": "20271231"}